NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-178-2014-2-PCT-01 RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE PCT PCT COMB PCT/US2015/048729 Expired
NCI E-272-2015-0-US-01 Genetically Mediated Modification Of Ion Transport To Augment Adoptive Cell Therapy US 62/214,765 Abandoned
NIAID E-076-2015-4-SG-18 METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION SG National Stage 11201701741Q Issued
NHGRI E-217-2007-0-CA-11 N-ACETYL MANNOSAMINE OR DERIVATIVES THEREOF FOR USE IN TREATING A KIDNEY DISORDER IN A MAMMAL CA DIV 2903133 Issued
NIAID E-076-2015-4-CA-05 VACCINE COMBINATION INCLUDING VECTORS COMPRISING NUCLEIC ACID ENCODING ANTIGENS FROM FILOVIRUS SUBTYPES CA National Stage 2960092 Issued
NIAID E-076-2015-4-IN-11 COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION IN National Stage 201717011032 Issued
NIAID E-076-2015-4-EP-08 METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION EP National Stage 15767631.3 Issued
NIAID E-076-2015-4-AU-03 METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION AU National Stage 2015311852 Issued
NIAID E-076-2015-5-AU-03 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES AU National Stage 2015311868 Issued
NIAID E-076-2015-4-JP-12 METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION JP National Stage 2017-512990 Issued
NIAID E-076-2015-5-NG-22 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES NG National Stage F/P/2017/122 Issued
NIDA E-073-2013-0-US-06 POTENT AND SELECTIVE INHIBITORS OF MONOAMINE TRANSPORTERS; METHOD OF MAKING; AND USE THEREOF US National Stage 14/772,486 9862679 Issued PDF
NIAID E-076-2015-5-PCT-01 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES PCT PCT COMB PCT/US2015/048388 Expired
NIAID E-076-2015-4-PCT-01 METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION PCT PCT COMB PCT/US15/048357 Expired
NIAID E-076-2015-5-CN-06 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES CN National Stage 201580055345.X Abandoned
NIAID E-076-2015-5-EP-08 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES EP National Stage 15771771.1 Abandoned
NIAID E-076-2015-5-JP-12 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES JP National Stage 2017-512836 Abandoned
NIAID E-076-2015-5-MY-15 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES MY National Stage PI 2017700702 Abandoned
NIAID E-076-2015-5-CA-05 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES CA National Stage 2960096 Abandoned
NIAID E-076-2015-5-KR-13 METHODS AND COMPOSITIONS FOR ENHANCING IMMUNE RESPONSES KR National Stage 10-2017-7008912 Pending
NIAID E-076-2015-5-ZA-21 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES ZA National Stage 2017/01813 Pending
NIAID E-076-2015-5-SG-18 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES SG National Stage 11201701745T Abandoned
NIAID E-076-2015-5-BR-04 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES BR National Stage BR1120170042029 Pending
NIAID E-076-2015-5-HK-09 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES HK National Stage 17113099.4 Abandoned
NIAID E-076-2015-5-IN-11 METHODS AND COMPOSITIONS FOR ENHANCING IMMUNE RESPONSES IN National Stage 201717010988 Abandoned
NIAID E-076-2015-4-UA-19 METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION UA National Stage a 2017 03034 Pending
NIAID E-076-2015-5-UA-19 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES UA National Stage a 2017 02986 Abandoned
NIAID E-076-2015-5-AP-02 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES AP National Stage AP/P/2017/009822 Pending
NIAID E-076-2015-5-EA-07 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES EA National Stage 210790507 Abandoned
NIAID E-076-2015-5-OA-17 METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES OA National Stage 120170076 Pending
NCI E-059-2013-0-JP-07 Methods of Producing Enriched Populations of Tumor-Reactive T Cells From Tumor JP National Stage 2015-560159 Issued
NHLBI E-165-2012-0-US-04 Direct Pressure-mediated Intrabone Delivery System For Cellular Therapeutics US National Stage 14/772,044 Abandoned
NIDCR E-190-2015-0-US-01 Methods Of Using Neodymium Magnet For Rapid Diagnosis Of Infectious And Autoimmune Diseases US 62/212,973 Abandoned
NCI E-085-2013-0-US-06 METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR REACTIVE T CELLS FROM PERIPHERAL BLOOD US National Stage 14/771,593 9844569 Issued PDF
NCI E-059-2013-0-US-09 METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR REACTIVE T CELLS FROM TUMOR US National Stage 14/771,615 Abandoned
NCI E-257-2014-0-PCT-02 Immunogenic Modulation By Endocrine Deprivation Therapy Improves Sensitivity Of Tumor Cells To Immune Mediated Lysis PCT PCT PCT/US2015/047538 Expired
NHGRI E-161-2015-0-US-01 A Method of Detecting Molecules in Proximity to a Target Molecule in a Sample US 62/211,160 Abandoned
NEI E-164-2014-0-EP-05 Methods and Compositions for Treating Leber Congenital Amaurosis EP National Stage 15760025.5 Issued
NEI E-164-2014-0-GB-09 Methods and Compositions for Treating Leber Congenital Amaurosis GB EP 15760025.5 Issued
NEI E-164-2014-0-FR-07 Methods and Compositions for Treating Leber Congenital Amaurosis FR EP 15760025.5 Issued
NEI E-164-2014-0-DE-08 Methods and Compositions for Treating Leber Congenital Amaurosis DE EP 15760025.5 Issued
NEI E-164-2014-0-CA-04 Methods and Compositions for Treating Leber Congenital Amaurosis CA National Stage 2959540 Issued
NIAID E-018-2010-0-US-10 Recombinant Modified Vaccina Ankara (MVA) Vaccina Virus Containing Restructured Insertion Sites US DIV 14/837,382 9879231 Issued PDF
NCI E-130-2011-0-US-06 Human Monoclonal Antibodies Specific for Glypican-3 and Uses Thereof US DIV 14/837,903 9394364 Issued PDF
NEI E-164-2014-0-PCT-02 Methods and Compositions for Treating Leber Congenital Amaurosis PCT PCT PCT/US2015/047209 Expired
NIAID E-256-2015-0-US-01 MODIFIED ANTHRAX TOXIN PROTECTIVE ANTIGEN US 62/210,771 Abandoned
NIBIB E-229-2015-0-US-01 Systems and Methods for Multi-View NonLinear Optical Imaging for Improved Signal-to-Noise Ratio and Resolution in Point Scanning Multi-Photon Microscopy US 62/210,153 Abandoned
NCI E-232-2015-0-US-01 T Cells Modified to Overexpress C-MYB US 62/209,497 Abandoned
NIAID E-145-2015-2-US-01 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV US 62/209,619 Abandoned
NIAID E-248-2006-0-US-19 Intergenic Sites Between Conserved Genes in the Genome of Modified Vaccinia Ankara (MVA) Vaccinia Virus US DIV 14/833,913 10421978 Issued PDF